Strain profile

Cherry On Top

91 BudWiki points91 research + 0 net votes × 25

Uncertain or conflicting parentage

Cherry On Top

Reported parentageGrape Pie × GMO

Source accounts differ.

Historical THC
28%
Highest listed terpenes
β-Caryophyllene 0.29% · Limonene 0.25% · β-Myrcene 0.24%

Flower profile

  • Reported effectsNot yet sourced
  • FlavorNot yet sourced
  • AromaNot yet sourced

Leave a Review

One review per strain per account · 240 characters

Loading reviews…

Your rating

Community reviews

Similar strains

Published family connections; batches may differ.

Shared lineage

No unambiguous parent or selection matches are available yet.

Similar names

Names only; ancestry unconfirmed.

Sources and research notes

Parentage sources

Seed & Strain’s reported version · Uncertain or conflicting account

Dutchie · first-party storefront — Seed & Strain product reference

Grower-specific claim from a previously retrieved first-party retailer menu. Applies to the named producer/product only; does not confirm another grower, cut, or batch. Source capture: 2026-09-09T06:48:50.804Z. Seed & Strain menu descriptions disagree between Grape Pie × GMO and Lemon Cherry Gelato × Udder Madness.

THC & terpenes

Sample and producer versions may differ. These references do not predict another batch’s contents.

THC · Grow West Maryland

Cherry On Top · Triple Seven

Grow West Maryland lists 28% THC in the exact Triple Seven Cherry On Top flower product reference. Parentage and batch identifier are not stated, so this does not authenticate another same-named breeder edition. This is an attributed producer/retailer value without an original COA or authenticated batch, not an expected cultivar-wide range.

Captured 2026-10-02
Terpenes · Sunburst Pharm

Cherry on Top · Seed and Strain

Historical flower listing. Sorted descending among this listing’s reported terpene measurements; no COA or batch identity is established. Producer, harvest and test method can change the order. Not a universal cultivar profile or a current-stock claim. Listed sum 1.040% versus reported total 1.1%; panel completeness not established

Captured 2026-09-08